About this Journal Submit a Manuscript Table of Contents
ISRN Endocrinology
Volume 2012 (2012), Article ID 947323, 11 pages
http://dx.doi.org/10.5402/2012/947323
Research Article

Sterculic Oil, a Natural SCD1 Inhibitor, Improves Glucose Tolerance in Obese ob/ob Mice

1Department of Nutrition and Exercise Physiology, University of Missouri, Columbia, MO 65211, USA
2Department of Food Science, University of Missouri, Columbia, MO 65211, USA
3Department of Animal Science, Cornell University, Ithaca, NY 14853, USA
4Department of Internal Medicine-Division of Gastroenterology and Hepatology, University of Missouri, Columbia, MO 65211, USA
5Division of Research Service, Harry S. Truman Memorial Veterans Medical Center, Columbia, MO 65201, USA
6Department of Animal Sciences, University of Missouri, Columbia, MO 65211, USA

Received 16 September 2012; Accepted 4 October 2012

Academic Editors: E. Al-Dujaili, B. Larijani, E. Spinedi, and J.-F. Tanti

Copyright © 2012 Laura C. Ortinau et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. “Vital signs: state-specific obesity prevalence among adults—United States, 2009,” Morbidity and Mortality Weekly Report, vol. 59, no. 30, pp. 951–955, 2010. View at Scopus
  2. K. Azuma, L. K. Heilbronn, J. B. Albu, S. R. Smith, E. Ravussin, and D. E. Kelley, “Adipose tissue distribution in relation to insulin resistance in type 2 diabetes mellitus,” American Journal of Physiology, vol. 293, no. 1, pp. E435–E442, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. G. A. Bray, K. A. Jablonski, W. Y. Fujimoto et al., “Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program,” American Journal of Clinical Nutrition, vol. 87, no. 5, pp. 1212–1218, 2008. View at Scopus
  4. R. E. C. Wildman, “Nutraceuticals: a brief review of historical and teleological aspects,” in Handbook of Nutraceuticals and Functional Foods, R. E. C. Wildman, Ed., pp. 2–12, CRC Press, Boca Raton, Fla, USA, 2000.
  5. C. P. F. Marinangeli and P. J. H. Jones, “Functional food ingredients as adjunctive therapies to pharmacotherapy for treating disorders of metabolic syndrome,” Annals of Medicine, vol. 42, no. 5, pp. 317–333, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Gahche, R. Bailey, V. Burt et al., “Dietary supplement use among U.S. adults has increased since NHANES III (1988–1994),” NCHS Data Brief, no. 61, pp. 1–8, 2011. View at Scopus
  7. P. S. Odegard, M. M. Janci, M. P. Foeppel, J. R. Beach, and D. L. Trence, “Prevalence and correlates of dietary supplement use in individuals with diabetes mellitus at an academic diabetes care clinic,” Diabetes Educator, vol. 37, no. 3, pp. 419–425, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Fabian, S. Töscher, I. Elmadfa, and T. R. Pieber, “Use of complementary and alternative medicine supplements in patients with diabetes mellitus,” Annals of Nutrition and Metabolism, vol. 58, no. 2, pp. 101–108, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. F. E. Gomez, D. E. Bauman, J. M. Ntambi, and B. G. Fox, “Effects of sterculic acid on stearoyl-CoA desaturase in differentiating 3T3-L1 adipocytes,” Biochemical and Biophysical Research Communications, vol. 300, no. 2, pp. 316–326, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. C. A. Major, K. Ryan, A. J. Bennett, A. L. Lock, D. E. Bauman, and A. M. Salter, “Inhibition of stearoyl CoA desaturase activity induces hypercholesterolemia in the cholesterol-fed hamster,” Journal of Lipid Research, vol. 49, no. 7, pp. 1456–1465, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. M. K. Pasha and F. Ahmad, “Analysis of triacylglycerols containing cyclopropene fatty acids in Sterculia foetida (Linn.) seed lipids,” Journal of Agricultural and Food Chemistry, vol. 40, no. 4, pp. 626–629, 1992. View at Scopus
  12. S. Aued-Pimentel, J. H. G. Lago, M. H. Chaves, and E. E. Kumagai, “Evaluation of a methylation procedure to determine cyclopropenoids fatty acids from Sterculia striata St. Hil. Et Nauds seed oil,” Journal of Chromatography A, vol. 1054, no. 1-2, pp. 235–239, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. P. A. Carpino and B. Goodwin, “Diabetes area participation analysis: a review of companies and targets described in the 2008–2010 patent literature,” Expert Opinion on Therapeutic Patents, vol. 20, no. 12, pp. 1627–1651, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Dobrzyn and J. M. Ntambi, “Stearoyl-CoA desaturase as a new drug target for obesity treatment,” Obesity Reviews, vol. 6, no. 2, pp. 169–174, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Warensjö, M. Öhrvall, and B. Vessby, “Fatty acid composition and estimated desaturase activities are associated with obesity and lifestyle variables in men and women,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 16, no. 2, pp. 128–136, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. A. D. Attie, R. M. Krauss, M. P. Gray-Keller et al., “Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia,” Journal of Lipid Research, vol. 43, no. 11, pp. 1899–1907, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. X. Liu, M. Miyazaki, and M. T. Flowers, “Loss of stearoyl-CoA desaturase-1 attenuates adipocyte inflamation, effects of adipocyte-derived oleate,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, pp. 31–38, 2010.
  18. M. Miyazaki, H. Sampath, X. Liu et al., “Stearoyl-CoA desaturase-1 deficiency attenuates obesity and insulin resistance in leptin-resistant obese mice,” Biochemical and Biophysical Research Communications, vol. 380, no. 4, pp. 818–822, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. A. L. Lock, B. A. Corl, D. M. Barbano, D. E. Bauman, and C. Ip, “The anticarcinogenic effect of trans-11 18:1 is dependent on its conversion to cis-9, trans-11 CLA by Δ9-desaturase in rats,” Journal of Nutrition, vol. 134, no. 10, pp. 2698–2704, 2004. View at Scopus
  20. B. A. Corl, L. H. Baumgard, J. M. Griinari et al., “Trans-7,cis-9 CLA is synthesized endogenously by δ9-desaturase in dairy cows,” Lipids, vol. 37, no. 7, pp. 681–688, 2002. View at Scopus
  21. D. G. Scarpelli, “Mitogenic activity of sterculic acid, a cyclopropenoid fatty acid,” Science, vol. 185, no. 4155, pp. 958–960, 1974. View at Scopus
  22. J. E. Nixon, J. K. Yoss, and T. A. Eisele, “Metabolism and tissue distribution of label from [9,10 methylene 14C] sterculic acid in the rat,” Lipids, vol. 12, no. 8, pp. 629–634, 1977. View at Scopus
  23. E. C. Coleman and L. Friedman, “Fatty acids in tissue lipids of rats fed Sterculia foetida oil,” Journal of Agricultural And Food Chemistry, vol. 19, no. 2, pp. 224–228, 1971. View at Scopus
  24. J. N. Roehm, D. J. Lee, J. H. Wales, S. D. Polityka, and R. O. Sinnhuber, “The effect of dietary sterculic acid on the hepatic lipids of rainbow trout,” Lipids, vol. 5, no. 1, pp. 80–84, 1970. View at Publisher · View at Google Scholar · View at Scopus
  25. T. A. Eisele, J. K. Yoss, and J. E. Nixon, “Rat urinary metabolites of [9,10 methylene 14C]sterculic acid,” Biochimica et Biophysica Acta, vol. 488, no. 1, pp. 76–87, 1977. View at Scopus
  26. W. W. Christie, “A simple procedure for rapid transmethylation of glycerolipids and cholesteryl esters,” Journal of Lipid Research, vol. 23, no. 7, pp. 1072–1075, 1982. View at Scopus
  27. D. M. Schwartz and N. E. Wolins, “A simple and rapid method to assay triacylglycerol in cells and tissues,” Journal of Lipid Research, vol. 48, no. 11, pp. 2514–2520, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. R. S. Rector, J. P. Thyfault, R. T. Morris et al., “Daily exercise increases hepatic fatty acid oxidation and prevents steatosis in Otsuka Long-Evans Tokushima Fatty rats,” American Journal of Physiology, vol. 294, no. 3, pp. G619–G626, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. M. W. Hulver, J. R. Berggren, M. J. Carper et al., “Elevated stearoyl-CoA desaturase-1 expression in skeletal muscle contributes to abnormal fatty acid partitioning in obese humans,” Cell Metabolism, vol. 2, no. 4, pp. 251–261, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Dobrzyn, A. Dobrzyn, M. Miyazaki, and J. M. Ntambi, “Loss of stearoyl-CoA desaturase 1 rescues cardiac function in obese leptin-deficient mice,” Journal of Lipid Research, vol. 51, no. 8, pp. 2202–2210, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. J. M. Ntambi, M. Miyazaki, J. P. Stoehr et al., “Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 17, pp. 11482–11486, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. G. Jiang, Z. Li, F. Liu et al., “Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase-1,” Journal of Clinical Investigation, vol. 115, no. 4, pp. 1030–1038, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Miyazaki, M. T. Flowers, H. Sampath et al., “Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosis,” Cell Metabolism, vol. 6, no. 6, pp. 484–496, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. M. T. Flowers, A. K. Groen, A. T. Oler et al., “Cholestasis and hypercholesterolemia in SCD1-deficient mice fed a low-fat, high-carbohydrate diet,” Journal of Lipid Research, vol. 47, no. 12, pp. 2668–2680, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. K. Chu, M. Miyazaki, W. C. Man, and J. M. Ntambi, “Stearoyl-coenzyme A desaturase 1 deficiency protects against hypertriglyceridemia and increases plasma high-density lipoprotein cholesterol induced by liver X receptor activation,” Molecular and Cellular Biology, vol. 26, no. 18, pp. 6786–6798, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. S. E. Shoelson, J. Lee, and A. B. Goldfine, “Inflammation and insulin resistance,” Journal of Clinical Investigation, vol. 116, no. 7, pp. 1793–1801, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. R. Gutiérrez-Juárez, A. Pocai, C. Mulas et al., “Critical role of stearoyl-CoA desaturase—1 (SCD1) in the onset of diet-induced hepatic insulin resistance,” Journal of Clinical Investigation, vol. 116, no. 6, pp. 1686–1695, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. C. K. Hyun, E. D. Kim, M. T. Flowers et al., “Adipose-specific deletion of stearoyl-CoA desaturase 1 up-regulates the glucose transporter GLUT1 in adipose tissue,” Biochemical and Biophysical Research Communications, vol. 399, no. 4, pp. 480–486, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. P. Dobrzyn, A. Dobrzyn, M. Miyazaki et al., “Stearoyl-CoA desaturase 1 deficiency increases fatty acid oxidation by activating AMP-activated protein kinase in liver,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 17, pp. 6409–6414, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Miyazaki, A. Dobrzyn, H. Sampath et al., “Reduced adiposity and liver steatosis by stearoyl-CoA desaturase deficiency are independent of peroxisome proliferator-activated receptor-α,” Journal of Biological Chemistry, vol. 279, no. 33, pp. 35017–35024, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Issandou, A. Bouillot, J. M. Brusq et al., “Pharmacological inhibition of Stearoyl-CoA Desaturase 1 improves insulin sensitivity in insulin-resistant rat models,” European Journal of Pharmacology, vol. 618, no. 1-3, pp. 28–36, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. J. B. Flowers, M. E. Rabaglia, K. L. Schueler et al., “Loss of stearoyl-CoA desaturase-1 improves insulin sensitivity in lean mice but worsens diabetes in leptin-deficient obese mice,” Diabetes, vol. 56, no. 5, pp. 1228–1239, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. S. B. Biddinger, M. Miyazaki, J. Boucher, J. M. Ntambi, and C. R. Kahn, “Leptin suppresses stearoyl-CoA desaturase 1 by mechanisms independent of insulin and sterol regulatory element-binding protein-1c,” Diabetes, vol. 55, no. 7, pp. 2032–2041, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. A. A. Wendel, L. O. Li, Y. Li, G. W. Cline, G. I. Shulman, and R. A. Coleman, “Glycerol-3-phosphate acyltransferase 1 deficiency in ob/ob mice diminishes hepatic steatosis but does not protect against insulin resistance or obesity,” Diabetes, vol. 59, no. 6, pp. 1321–1329, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. N. Yahagi, H. Shimano, A. H. Hasty et al., “Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lepob/Lepob mice,” Journal of Biological Chemistry, vol. 277, no. 22, pp. 19353–19357, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. N. Kumashiro, D. M. Erion, D. Zhang et al., “Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 39, pp. 16381–16385, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. V. T. Samuel, Z. X. Liu, X. Qu et al., “Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease,” Journal of Biological Chemistry, vol. 279, no. 31, pp. 32345–32353, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Dresner, D. Laurent, M. Marcucci et al., “Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity,” Journal of Clinical Investigation, vol. 103, no. 2, pp. 253–259, 1999. View at Scopus
  49. T. K. T. Lam, G. Van de Werve, and A. Giacca, “Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites,” American Journal of Physiology, vol. 284, no. 2, pp. E281–E290, 2003. View at Scopus
  50. M. T. A. Nguyen, S. Favelyukis, A. K. Nguyen et al., “A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via toll-like receptors 2 and 4 and JNK-dependent pathways,” Journal of Biological Chemistry, vol. 282, no. 48, pp. 35279–35292, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. H. Shi, M. V. Kokoeva, K. Inouye, I. Tzameli, H. Yin, and J. S. Flier, “TLR4 links innate immunity and fatty acid-induced insulin resistance,” Journal of Clinical Investigation, vol. 116, no. 11, pp. 3015–3025, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. J. J. Senn, P. J. Klover, I. A. Nowak, and R. A. Mooney, “Interleukin-6 induces cellular insulin resistance in hepatocytes,” Diabetes, vol. 51, no. 12, pp. 3391–3399, 2002. View at Scopus
  53. V. Rotter, I. Nagaev, and U. Smith, “Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects,” Journal of Biological Chemistry, vol. 278, no. 46, pp. 45777–45784, 2003. View at Publisher · View at Google Scholar · View at Scopus
  54. C. Lagathu, J. P. Bastard, M. Auclair, M. Maachi, J. Capeau, and M. Caron, “Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone,” Biochemical and Biophysical Research Communications, vol. 311, no. 2, pp. 372–379, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. A. L. Carey, G. R. Steinberg, S. L. Macaulay et al., “Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase,” Diabetes, vol. 55, no. 10, pp. 2688–2697, 2006. View at Publisher · View at Google Scholar · View at Scopus
  56. A. G. Holmes, J. L. Mesa, B. A. Neill et al., “Prolonged interleukin-6 administration enhances glucose tolerance and increases skeletal muscle PPARα and UCP2 expression in rats,” Journal of Endocrinology, vol. 198, no. 2, pp. 367–374, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. H. Ellingsgaard, I. Hauselmann, B. Schuler et al., “Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells,” Nature Medicine, vol. 17, no. 11, pp. 1481–1489, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. S. M. Rahman, A. Dobrzyn, P. Dobrzyn, S. H. Lee, M. Miyazaki, and J. M. Ntambi, “Stearoyl-CoA desaturase 1 deficiency elevates insulin-signaling components and down-regulates protein-tyrosine phosphatase 1B in muscle,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 19, pp. 11110–11115, 2003. View at Publisher · View at Google Scholar · View at Scopus
  59. P. K. Raju and R. Reiser, “Inhibition of fatty acyl desaturase by cyclopropene fatty acids,” Journal of Biological Chemistry, vol. 242, no. 3, pp. 379–384, 1967. View at Scopus
  60. S. Reagan-Shaw, M. Nihal, and N. Ahmad, “Dose translation from animal to human studies revisited,” FASEB Journal, vol. 22, no. 3, pp. 659–661, 2008. View at Publisher · View at Google Scholar · View at Scopus